XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Net Loss Attributable to Common Stockholders per Share (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of (Loss) Income per Share
For purposes of the diluted net loss attributable to common stockholders per share calculation, outstanding stock options, unvested RSAs, unvested RSUs, conversion option derivative under the K2HV Loan Agreement, and warrants to purchase common stock are considered to be potentially dilutive securities, however the following outstanding shares of common stock equivalents were excluded from the calculation of diluted net loss attributable to common stockholders per share because their effect would be anti-dilutive:
June 30,
20242023
Outstanding stock options
7,510,033 6,745,934 
Unvested RSUs150,000 316,500 
Warrants to purchase common stock
58,904 58,904 
Common stock to be issued under the 2021 ESPP
36,767 18,366 
Total
7,755,704 7,139,704 
Schedule of Calculation of Basic and Diluted Net (Loss) Income per Share
Three Months Ended June 30,
Six Months Ended June 30,
2024202320242023
Numerator
Net loss$(17,249)$(5,098)$(33,442)$(17,080)
Less: Change in fair value of derivative liability
(1,609)— (1,609)— 
Plus: Interest expense on converted term loan120 — 120 — 
Adjusted net loss$(18,738)$(5,098)$(34,931)$(17,080)
Denominator
Weighted-average common stock outstanding, basic43,521,406 35,557,701 42,564,342 35,173,327 
Dilutive effect of common stock issuable from assumed conversion of convertible term loan
521,778 — 260,889 — 
Weighted-average common stock outstanding, diluted44,043,184 35,557,701 42,825,231 35,173,327 
Net loss per share
Basic$(0.40)$(0.14)$(0.79)$(0.49)
Diluted$(0.43)$(0.14)$(0.82)$(0.49)